|
 |
Late Stage Drug Development World 2009 |
|
|
1-4 December 2009
London, UK
Late stage drug development is growing at around 20% annually, exceeding the growth rate of Phase II and III Trials. In excess of $12 billion is currently being spent on Phase IIIb/IV studies as public concerns on the safety of approved drugs prevail together with the need to evaluate real world safety and effectiveness of marketed drugs. More than ever before there is the urgent need to detect, quantify and communicate patient risk with speed and efficiency. As a result, Health Network Communications is delighted to announce the first ever strategic forum addressing the major challenges in conducting strategic and compliant late stage studies.
The Bloomsbury Hotel, London, United Kingdom
www.healthnetworkcommunications.com/2009/LSDD
Tel: +44 (0) 207 608 7055
Fax: +44 (0) 207 608 7050
Email: jphillips@healthnetworkcommunications.com |
|
|
|
|
|
|
|
 |
Industry Events |
 |
Discovery Summit 2010
22-24 March 2010, Cannes, France
The Discovery Summit 2010 will highlight the industry’s current challenges and opportunities on a global level through international keynote presentations and case studies delivered by the most esteemed thought leaders in the industry.
More info >> |
|
 |
News and Press Releases |
 |
2010 BIO International Convention Expected to Bring More Than $25 Million to Chicago
The Biotechnology Industry Organization announced today that the 2010 BIO International Convention is expected to contribute more than $25 million to the local economy, according to estimates from the Chicago Convention and Tourism Bureau. The BIO International Convention returns to Chicago on 3rd-6th May and is expected to draw 15,000 to 17,000 industry leaders from 48 states and 60 countries.
More info >> |
|
|
